Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2013

01.06.2013 | Epidemiology

Racial disparities in clinical presentation, surgical treatment and in-hospital outcomes of women with breast cancer: analysis of nationwide inpatient sample database

verfasst von: Ahmed Dehal, Ali Abbas, Samir Johna

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

To examine racial/ethnic disparities in stage of disease and comorbidity (pre-treatment), surgical treatment allocation (breast-conserving surgery versus mastectomy), and in-hospital outcomes after surgery (post-treatment) among women with breast cancer. Nationwide inpatient sample is a nationwide clinical and administrative database compiled from 44 states representing 95 % of all hospital discharges in the Unites States. Discharges of adult women who underwent surgery for breast cancer from 2005 to 2009 were identified. Information about patients and hospitals characteristics was obtained. Multivariate logistic regression analyses were used to examine the risk adjusted association between race/ethnicity and the aforementioned outcomes (pre-treatment, treatment, and post-treatment). We identified 75,100 patient discharges. Compared to Whites, African-Americans (1.17, p < 0.001), and Hispanics (1.20, p < 0.001) were more likely to present with regional or metastatic disease. Similarly, African-American (1.58, p < 0.001) and Hispanics (1.11, p 0.003) were more likely to have comorbidity. Compared to Whites, African-Americans (0.71, p < 0.001), and Hispanics (0.77, p < 0.001) were less likely to receive mastectomy. Compared to Whites, African-Americans were more likely to develop post-operative complications (1.35, p < 0.001) and in-hospital mortality (1.87, p 0.13). Other racial groups showed no statistically significant difference compared to Whites. After controlling for potential confounders, we found racial/ethnic disparities in stage, comorbidity, surgical treatment allocation, and in-hospital outcomes among women with breast cancer. Future researches should examine the underlying factors of these disparities.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat National Institutes of Health Consensus Development Conference Statement (1990) Treatment of early-stage breast cancer. National Institutes of Health National Institutes of Health Consensus Development Conference Statement (1990) Treatment of early-stage breast cancer. National Institutes of Health
2.
Zurück zum Zitat National Institutes of Health Consensus Conference (1991) Treatment of early-stage breast cancer. JAMA 265:391–395CrossRef National Institutes of Health Consensus Conference (1991) Treatment of early-stage breast cancer. JAMA 265:391–395CrossRef
3.
Zurück zum Zitat The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (1998) Mastectomy or lumpectomy? the choice of operation for clinical stages I and II breast cancer. Can Med Assoc J 158(Suppl 3):S15–S21 The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (1998) Mastectomy or lumpectomy? the choice of operation for clinical stages I and II breast cancer. Can Med Assoc J 158(Suppl 3):S15–S21
4.
Zurück zum Zitat Council on Scientific Affairs, American Medical Association (1993) Report of the council on scientific affairs: management of patients with node-negative breast cancer. Arch Intern Med 153:58–67CrossRef Council on Scientific Affairs, American Medical Association (1993) Report of the council on scientific affairs: management of patients with node-negative breast cancer. Arch Intern Med 153:58–67CrossRef
5.
Zurück zum Zitat Lazovich D, White E, Thomas D, Moe R (1991) Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 266:3433–3438PubMedCrossRef Lazovich D, White E, Thomas D, Moe R (1991) Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 266:3433–3438PubMedCrossRef
6.
Zurück zum Zitat Nattinger A, Gottlieb M, Veum J et al (1992) Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326:1102–1107PubMedCrossRef Nattinger A, Gottlieb M, Veum J et al (1992) Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326:1102–1107PubMedCrossRef
7.
Zurück zum Zitat Nattinger A, Gottlieb M, Hoffman R et al (1996) Minimal increase in use of breast-conserving surgery from 1986 to 1990. Med Care 34:479–489PubMedCrossRef Nattinger A, Gottlieb M, Hoffman R et al (1996) Minimal increase in use of breast-conserving surgery from 1986 to 1990. Med Care 34:479–489PubMedCrossRef
8.
Zurück zum Zitat Farrow D, Hunt W, Samet J (1992) Geographic variation in the treatment of localized breast cancer. N Engl J Med 326:1097–1101PubMedCrossRef Farrow D, Hunt W, Samet J (1992) Geographic variation in the treatment of localized breast cancer. N Engl J Med 326:1097–1101PubMedCrossRef
9.
Zurück zum Zitat Dayal H, Power R, Chiu C (1982) Race and socio-economic status in survival from breast cancer. J Chron Dis 35:675–683PubMedCrossRef Dayal H, Power R, Chiu C (1982) Race and socio-economic status in survival from breast cancer. J Chron Dis 35:675–683PubMedCrossRef
10.
Zurück zum Zitat Eley JW, Hill HA, Chen VW et al (1994) Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272:947–954PubMedCrossRef Eley JW, Hill HA, Chen VW et al (1994) Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272:947–954PubMedCrossRef
11.
Zurück zum Zitat McWhorter WP, Mayer WJ (1987) Black/White differences in type of initial breast cancer treatment and implications for survival. Am J Public Health 77:1515–1517PubMedCrossRef McWhorter WP, Mayer WJ (1987) Black/White differences in type of initial breast cancer treatment and implications for survival. Am J Public Health 77:1515–1517PubMedCrossRef
12.
Zurück zum Zitat Blackman DJ, Masi CM (2006) Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes. J Clin Oncol 14:2170–2178CrossRef Blackman DJ, Masi CM (2006) Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes. J Clin Oncol 14:2170–2178CrossRef
13.
Zurück zum Zitat Joslyn SA (2002) Racial differences in treatment and survival from early-stage breast carcinoma. Cancer 95:1759–1766PubMedCrossRef Joslyn SA (2002) Racial differences in treatment and survival from early-stage breast carcinoma. Cancer 95:1759–1766PubMedCrossRef
14.
Zurück zum Zitat Tammemagi CM, Nerenz D, Neslund-Dudas C et al (2005) Comorbidity and survival disparities among Black and White patients with breast cancer. JAMA 294:1765–1772PubMedCrossRef Tammemagi CM, Nerenz D, Neslund-Dudas C et al (2005) Comorbidity and survival disparities among Black and White patients with breast cancer. JAMA 294:1765–1772PubMedCrossRef
15.
Zurück zum Zitat Li CI, Malone KE, Daling JR (2003) Difference in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163:49–56PubMedCrossRef Li CI, Malone KE, Daling JR (2003) Difference in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163:49–56PubMedCrossRef
16.
Zurück zum Zitat Hershman D, McBride R, Jacobson JS et al (2005) Racial disparities in treatment and survival among women with early stage breast cancer. J Clin Oncol 23:6639–6646PubMedCrossRef Hershman D, McBride R, Jacobson JS et al (2005) Racial disparities in treatment and survival among women with early stage breast cancer. J Clin Oncol 23:6639–6646PubMedCrossRef
19.
Zurück zum Zitat Zhang S, Ivy JS, Payton FC et al (2010) Modeling the impact of comorbidity on breast cancer patient outcomes. Health Care Manag Sci 13:137–154PubMedCrossRef Zhang S, Ivy JS, Payton FC et al (2010) Modeling the impact of comorbidity on breast cancer patient outcomes. Health Care Manag Sci 13:137–154PubMedCrossRef
20.
Zurück zum Zitat Polek C, Klemm P, Hardie T et al (2004) Asian/Pacific Islander American women: age and death rates during hospitalization for breast cancer. Oncol Nurs Forum 31:E69–E74PubMedCrossRef Polek C, Klemm P, Hardie T et al (2004) Asian/Pacific Islander American women: age and death rates during hospitalization for breast cancer. Oncol Nurs Forum 31:E69–E74PubMedCrossRef
21.
Zurück zum Zitat Kotwall C, Brinker C, Covington D et al (2003) Local and national trends over a decade in the surgical treatment of ductal carcinoma in situ. Am J Surg 186:723–728PubMedCrossRef Kotwall C, Brinker C, Covington D et al (2003) Local and national trends over a decade in the surgical treatment of ductal carcinoma in situ. Am J Surg 186:723–728PubMedCrossRef
22.
Zurück zum Zitat Case C, Johantgen M, Steiner C (2001) Outpatient mastectomy: clinical, payer, and geographic influences. Health Serv Res 36:869–884PubMed Case C, Johantgen M, Steiner C (2001) Outpatient mastectomy: clinical, payer, and geographic influences. Health Serv Res 36:869–884PubMed
23.
Zurück zum Zitat Reuben BC, Manwaring J, Neumayer LA (2009) Recent trends and predictors in immediate breast reconstruction after mastectomy in the United States. Am J Surg 198:237–243PubMedCrossRef Reuben BC, Manwaring J, Neumayer LA (2009) Recent trends and predictors in immediate breast reconstruction after mastectomy in the United States. Am J Surg 198:237–243PubMedCrossRef
24.
Zurück zum Zitat Guller U, Safford S, Pietrobon R et al (2005) High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233,247 patients. World J Surg 29:994–1000PubMedCrossRef Guller U, Safford S, Pietrobon R et al (2005) High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233,247 patients. World J Surg 29:994–1000PubMedCrossRef
25.
Zurück zum Zitat Birkmeyer JD, Siewers AE, Finlayson EVA et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137PubMedCrossRef Birkmeyer JD, Siewers AE, Finlayson EVA et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137PubMedCrossRef
26.
Zurück zum Zitat Gonnella JS (1996) Disease Staging, 4th edn. The MEDSTAT Group, Ann Arbor Gonnella JS (1996) Disease Staging, 4th edn. The MEDSTAT Group, Ann Arbor
27.
Zurück zum Zitat Iezzoni LI, Ash AS, Shwartz M et al (1995) Predicting who dies depends on how severity is measured: implications for evaluating patient outcomes. Ann Intern Med 123:763–770PubMedCrossRef Iezzoni LI, Ash AS, Shwartz M et al (1995) Predicting who dies depends on how severity is measured: implications for evaluating patient outcomes. Ann Intern Med 123:763–770PubMedCrossRef
28.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383PubMedCrossRef
29.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9 CM administrative databases. J Clin Epidemiol 45:613–619PubMedCrossRef Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9 CM administrative databases. J Clin Epidemiol 45:613–619PubMedCrossRef
30.
Zurück zum Zitat Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139PubMedCrossRef Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139PubMedCrossRef
31.
Zurück zum Zitat Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97:1143–1147CrossRef Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97:1143–1147CrossRef
32.
Zurück zum Zitat Dimick JB, Wainess RM, Upchurch GR Jr et al (2005) National trends in outcomes for esophageal resection. Ann Thorac Surg 79:212–216PubMedCrossRef Dimick JB, Wainess RM, Upchurch GR Jr et al (2005) National trends in outcomes for esophageal resection. Ann Thorac Surg 79:212–216PubMedCrossRef
33.
Zurück zum Zitat Finlayson EV, Goodney PP, Birkmeyer JD (2003) Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg 138:721–725PubMedCrossRef Finlayson EV, Goodney PP, Birkmeyer JD (2003) Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg 138:721–725PubMedCrossRef
34.
Zurück zum Zitat Elmore JG, Moceri VM, Carter D et al (1998) Breast cancer tumor characteristics in Black and White women. Cancer 83:2509–2515PubMedCrossRef Elmore JG, Moceri VM, Carter D et al (1998) Breast cancer tumor characteristics in Black and White women. Cancer 83:2509–2515PubMedCrossRef
35.
Zurück zum Zitat Weiss HA, Brinton LA, Bragon D (1996) Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 73:1298–1305PubMedCrossRef Weiss HA, Brinton LA, Bragon D (1996) Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 73:1298–1305PubMedCrossRef
36.
Zurück zum Zitat Weinick RM (2000) Experience of primary care by racial and ethnic groups. Med Care 38:447–448PubMedCrossRef Weinick RM (2000) Experience of primary care by racial and ethnic groups. Med Care 38:447–448PubMedCrossRef
37.
Zurück zum Zitat Swan J, Breen N, Coates RJ et al (2003) Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Study. Cancer 97:1528–1540PubMedCrossRef Swan J, Breen N, Coates RJ et al (2003) Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Study. Cancer 97:1528–1540PubMedCrossRef
38.
Zurück zum Zitat Phillips JM, Cohen MZ, Moses G (1999) Breast cancer screening and African-American women: fear, fatalism, and silence. Oncol Nurs Forum 26:561–571PubMed Phillips JM, Cohen MZ, Moses G (1999) Breast cancer screening and African-American women: fear, fatalism, and silence. Oncol Nurs Forum 26:561–571PubMed
39.
Zurück zum Zitat Weiss HA, Brinton LA, Brogan D et al (1996) Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 73:1298–1305PubMedCrossRef Weiss HA, Brinton LA, Brogan D et al (1996) Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 73:1298–1305PubMedCrossRef
40.
Zurück zum Zitat Waidmann TA, Rajan S (2000) Race and ethnic disparities in health care access and utilization: an examination of state variation. Med Care Res Rev 57:55–84PubMed Waidmann TA, Rajan S (2000) Race and ethnic disparities in health care access and utilization: an examination of state variation. Med Care Res Rev 57:55–84PubMed
41.
Zurück zum Zitat Michalski TA, Nattinger AB (1997) The influence of black race and socioeconomic status on the use of breast-conserving surgery for medicare beneficiaries. Cancer 79:314–319PubMedCrossRef Michalski TA, Nattinger AB (1997) The influence of black race and socioeconomic status on the use of breast-conserving surgery for medicare beneficiaries. Cancer 79:314–319PubMedCrossRef
42.
Zurück zum Zitat Nattinger AB, Gottlieb MS, Veum J et al (1992) Geographic variation in the use of breast- conserving treatment for breast cancer. N Engl J Med 326:1102–1107PubMedCrossRef Nattinger AB, Gottlieb MS, Veum J et al (1992) Geographic variation in the use of breast- conserving treatment for breast cancer. N Engl J Med 326:1102–1107PubMedCrossRef
43.
Zurück zum Zitat Enewold L, Zhou J, McGlynn KA et al (2012) Racial variation in breast cancer treatment among department of defense beneficiaries. Cancer 118:812–820PubMedCrossRef Enewold L, Zhou J, McGlynn KA et al (2012) Racial variation in breast cancer treatment among department of defense beneficiaries. Cancer 118:812–820PubMedCrossRef
44.
Zurück zum Zitat Shavers VL, Shavers BS (2006) Racism and health inequity among Americans. J Natl Med Assoc 98:386–396PubMed Shavers VL, Shavers BS (2006) Racism and health inequity among Americans. J Natl Med Assoc 98:386–396PubMed
45.
Zurück zum Zitat Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94:490–496PubMedCrossRef Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94:490–496PubMedCrossRef
46.
Zurück zum Zitat Morris CR (2000) Increasing trends in the use of breast conserving surgery in California. Am J Public Health 90:281–284PubMedCrossRef Morris CR (2000) Increasing trends in the use of breast conserving surgery in California. Am J Public Health 90:281–284PubMedCrossRef
47.
Zurück zum Zitat Dragun AE, Pan J, Riley EC et al (2012) Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14 year report from a comprehensive cancer center. Am J Clin Oncol (in press) Dragun AE, Pan J, Riley EC et al (2012) Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14 year report from a comprehensive cancer center. Am J Clin Oncol (in press)
48.
Zurück zum Zitat Dehal A, Abbas A, Johna S (2013) Comorbidity and outcomes after surgery among women with breast cancer: analysis of nationwide inpatient sample database. Breast Cancer Res Treat. doi:10.1007/s10549-013-2543-9 Dehal A, Abbas A, Johna S (2013) Comorbidity and outcomes after surgery among women with breast cancer: analysis of nationwide inpatient sample database. Breast Cancer Res Treat. doi:10.​1007/​s10549-013-2543-9
49.
Zurück zum Zitat McGuire KP, Santillan AA, Kaur P et al (2009) Are mastectomy on the rise? a 13 year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 16:2682–2690PubMedCrossRef McGuire KP, Santillan AA, Kaur P et al (2009) Are mastectomy on the rise? a 13 year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 16:2682–2690PubMedCrossRef
50.
Zurück zum Zitat Katipamula R, Degnim AC, Hoskin T et al (2009) Trends in mastectomy rates at the: mayo clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082–4088PubMedCrossRef Katipamula R, Degnim AC, Hoskin T et al (2009) Trends in mastectomy rates at the: mayo clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082–4088PubMedCrossRef
Metadaten
Titel
Racial disparities in clinical presentation, surgical treatment and in-hospital outcomes of women with breast cancer: analysis of nationwide inpatient sample database
verfasst von
Ahmed Dehal
Ali Abbas
Samir Johna
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2013
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2567-1

Weitere Artikel der Ausgabe 2/2013

Breast Cancer Research and Treatment 2/2013 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.